General Information of Drug (ID: DMK4N2F)

Drug Name
16-(2',2'-Dimethyl)-propylidene-estradiol
Synonyms SCHEMBL12379675
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 1 Molecular Weight (mw) 340.5
Logarithm of the Partition Coefficient (xlogp) 5.2
Rotatable Bond Count (rotbonds) 1
Hydrogen Bond Donor Count (hbonddonor) 2
Hydrogen Bond Acceptor Count (hbondacc) 2
Chemical Identifiers
Formula
C23H32O2
IUPAC Name
(13S,16E,17S)-16-(2,2-dimethylpropylidene)-13-methyl-7,8,9,11,12,14,15,17-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
Canonical SMILES
C[C@]12CCC3C(C1C/C(=C\\C(C)(C)C)/[C@@H]2O)CCC4=C3C=CC(=C4)O
InChI
InChI=1S/C23H32O2/c1-22(2,3)13-15-12-20-19-7-5-14-11-16(24)6-8-17(14)18(19)9-10-23(20,4)21(15)25/h6,8,11,13,18-21,24-25H,5,7,9-10,12H2,1-4H3/b15-13+/t18?,19?,20?,21-,23-/m0/s1
InChIKey
GJYCOULXILNZBK-LBIHAFKNSA-N
Cross-matching ID
PubChem CID
44407372
TTD ID
D06ZNI

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) TTIWB6L DHB1_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Modification of estrone at the 6, 16, and 17 positions: novel potent inhibitors of 17beta-hydroxysteroid dehydrogenase type 1. J Med Chem. 2006 Feb 23;49(4):1325-45.